Cargando…

Germline microsatellite genotypes differentiate children with medulloblastoma

BACKGROUND: The germline genetic events underpinning medulloblastoma (MB) initiation, and therefore the ability to determine who is at risk, are still unknown for the majority of cases. Microsatellites are short repeated sequences that make up ~3% of the genome. Repeat lengths vary among individuals...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivero-Hinojosa, Samuel, Kinney, Nicholas, Garner, Harold R, Rood, Brian R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Pediatric Neuro-Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954392/ https://www.ncbi.nlm.nih.gov/pubmed/31562520 http://dx.doi.org/10.1093/neuonc/noz179

Ejemplares similares

Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2020)

Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants
por: Stundon, Jennifer L, et al.
Publicado: (2022)

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)
por: Desai, Ami V, et al.
Publicado: (2022)

Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma
por: Plotkin, Scott R, et al.
Publicado: (2023)

Multi-ancestry genome-wide association study of 4069 children with glioma identifies 9p21.3 risk locus
por: Foss-Skiftesvik, Jon, et al.
Publicado: (2023)

Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg Study
por: Peters, Sarah, et al.
Publicado: (2021)

Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908
por: Dunkel, Ira J, et al.
Publicado: (2023)

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma
por: Cantor, Evan, et al.
Publicado: (2022)

Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study
por: Chapman, Rebecca J, et al.
Publicado: (2023)

Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening
por: Kojic, Marija, et al.
Publicado: (2023)

CAGm: a repository of germline microsatellite variations in the 1000 genomes project
por: Kinney, Nicholas, et al.
Publicado: (2019)

Mapping pediatric brain tumors to their origins in the developing cerebellum
por: Okonechnikov, Konstantin, et al.
Publicado: (2023)

Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
por: Doz, François, et al.
Publicado: (2021)

Challenges for the functional diffusion map in pediatric brain tumors
por: Grech-Sollars, Matthew, et al.
Publicado: (2014)

Association between hippocampal dose and memory in survivors of childhood or adolescent low-grade glioma: a 10-year neurocognitive longitudinal study
por: Acharya, Sahaja, et al.
Publicado: (2019)

WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial
por: Varlet, Pascale, et al.
Publicado: (2020)

Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas
por: Shen, Han, et al.
Publicado: (2020)

Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant
por: de Billy, Emmanuel, et al.
Publicado: (2021)

A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomes
por: Green, Katherine, et al.
Publicado: (2022)

The clinical and molecular characteristics of progressive hypothalamic/optic pathway pilocytic astrocytoma
por: Li, Xiaoyu, et al.
Publicado: (2022)

LINC-23. Factors influencing outcomes of older children with Medulloblastoma over 15 years in Peru, a resource limited setting
por: Diaz-Coronado, Rosdali, et al.
Publicado: (2022)

LINC-41. TREATMENT OF RECURRENT MEDULLOBLASTOMA IN CHILDREN IN LOW INCOME SETTINGS
por: Kizyma, Roman, et al.
Publicado: (2020)

Outcomes of adult medulloblastoma treated with a multimodality approach: A tertiary cancer center experience
por: Mallick, Supriya, et al.
Publicado: (2015)

IMMU-15. PROTEOGENOMIC DISCOVERY OF NOVEL TUMOR PEPTIDES AS NEOANTIGENS FOR PERSONALIZED T CELL IMMUNOTHERAPY IN MEDULLOBLASTOMA
por: Rivero-Hinojosa, Samuel, et al.
Publicado: (2020)

Challenges Conveying Clinical Equipoise and Exploring Patient Treatment Preferences in an Oncology Trial Comparing Active Monitoring with Radiotherapy (ROAM/EORTC 1308)
por: Sherratt, Frances C., et al.
Publicado: (2020)

MDB-17. THE PTBP2 SPLICING FACTOR IS ESSENTIAL IN GROUP 3/4 MEDULLOBLASTOMA
por: Caisova, Veronika, et al.
Publicado: (2023)

Adult medulloblastoma: A rare case report and literature review
por: Faried, Ahmad, et al.
Publicado: (2016)

Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas
por: Karunasena, Enusha, et al.
Publicado: (2014)

Early-stage differentiation between presenile Alzheimer’s disease and frontotemporal dementia using arterial spin labeling MRI
por: Steketee, Rebecca M. E., et al.
Publicado: (2015)

Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas
por: Schramm, Peter, et al.
Publicado: (2010)

Brain deposition of gadobutrol in children—a cross-sectional and longitudinal MRI T1 mapping study
por: Gräfe, Daniel, et al.
Publicado: (2022)

Defining Treatment‐Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment‐Induced Necrosis
por: Winter, Sebastian F., et al.
Publicado: (2020)

Comprehensive Genomic Profiling of 282 Pediatric Low‐ and High‐Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures
por: Johnson, Adrienne, et al.
Publicado: (2017)

Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling
por: Yu, Xiaojun, et al.
Publicado: (2023)

LINC-15. OUTCOME OF CHINESE CHILDREN WITH MEDULLOBLASTOMA: A MULTI-CENTER EXPERIENCE WITH RISK-ADAPTED THERAPY
por: Sun, Xiaofei, et al.
Publicado: (2020)

Molecular imaging of 1p/19q deletion in oligodendroglial tumours with (11)C-methionine positron emission tomography
por: Iwadate, Yasuo, et al.
Publicado: (2016)

Integration of Tumor‐Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies
por: Wang, Yuefeng, et al.
Publicado: (2019)

Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study
por: Garnier, Louis, et al.
Publicado: (2022)

The use of eye‐movement recording in patients with anti‐Hu antibody–associated paraneoplastic neurological syndromes to objectively determine extent and course of disease
por: Janssen, Malou, et al.
Publicado: (2021)

The APOE ε4 allele in relation to pre‐ and postsurgical cognitive functioning of patients with primary brain tumors
por: Butterbrod, Elke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qt2rn8v1a2ep166p50dptnsgjj